Multiple studies have since associated the loss of function of pRB not only with retinoblastoma but with multiple other non-ocular malignancies, including osteosarcoma, cutaneous melanoma, and soft tissue sarcomas [35,36]. This evidence concerns the gene RB1 and retinoblastoma.